ENTITY
Lifetech Scientific

Lifetech Scientific (1302 HK)

32
Analysis
Health CareChina
Lifetech Scientific Corporation develops, manufactures and markets minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company produces congenital heart defect occluders, vena cava filters, stent grafts, balloon catheters, and vascular plugs.
more
Refresh
18 Dec 2022 09:17

China Healthcare Weekly (Dec.16) - ICU Expansion, Abnormal Medical Demand, Dying Chapter 18A of HKEX

Investor should treat ICU expansion rationally due to staff shortage. Demand during COVID was abnormal, which may have natural growth in 23H2. IPO...

Logo
452 Views
Share
26 Oct 2022 08:38

Shanghai Bio-Heart Biological Technology (2185.HK) - The Bubble Will Eventually Burst

Bio-heart’s core products lack competitiveness, with high uncertainties in commercialization outlook. High valuation is maintained so as to get...

Logo
170 Views
Share
23 Oct 2022 09:24

China Healthcare Weekly (Oct.21) - Electrophysiology VBP; Orthodontics VBP New Progress; HPV Vaccine

Unlike others' optimism,we see potential concerns in electrophysiology VBP; Orthodontics VBP is beyond expectation since invisible braces are...

Logo
306 Views
Share
11 Sep 2022 09:08

China Healthcare Weekly(Sep9)-Innovative Device Policy,Commercial Success Definition,Don't Be Fooled

We recommend cautiously optimistic about new innovative device policy. It's important to clarify what constitutes "commercialization success". All...

Logo
337 Views
Share
10 May 2022 08:52

Shanghai Microport Endovascular MedTech (688016.CH) 21/22Q1 - This Is a Company Worth Investing In

Endovascular’s product lines and promising internationalization will bring strong growth. The centralized procurement wouldn't be a concern for the...

Logo
324 Views
Share
x